Beaumont Jl

486 total citations
94 papers, 364 citations indexed

About

Beaumont Jl is a scholar working on Hematology, Surgery and Cancer Research. According to data from OpenAlex, Beaumont Jl has authored 94 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 15 papers in Surgery and 13 papers in Cancer Research. Recurrent topics in Beaumont Jl's work include Cancer, Lipids, and Metabolism (11 papers), Lipid metabolism and disorders (7 papers) and Cholesterol and Lipid Metabolism (6 papers). Beaumont Jl is often cited by papers focused on Cancer, Lipids, and Metabolism (11 papers), Lipid metabolism and disorders (7 papers) and Cholesterol and Lipid Metabolism (6 papers). Beaumont Jl collaborates with scholars based in France. Beaumont Jl's co-authors include N Lemort, B Jacotot, C. Dachet, Bernadette Delplanque, J Bernard, J Lenègre, Leandro Lorenzelli, J Caen, Fernand G. Péron and Lagrange Jl and has published in prestigious journals such as Clinical & Experimental Immunology, Bone Marrow Transplantation and PubMed.

In The Last Decade

Beaumont Jl

76 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beaumont Jl France 9 94 89 71 55 49 94 364
Per Teisberg Norway 11 68 0.7× 88 1.0× 155 2.2× 33 0.6× 21 0.4× 21 414
B J Zitelli United States 8 70 0.7× 256 2.9× 24 0.3× 48 0.9× 57 1.2× 11 544
O. Bogenschütz Germany 7 31 0.3× 73 0.8× 99 1.4× 46 0.8× 39 0.8× 11 717
Kalpna Desai United Kingdom 8 51 0.5× 109 1.2× 59 0.8× 50 0.9× 20 0.4× 15 345
Chuichi Itoh Japan 14 33 0.4× 86 1.0× 25 0.4× 26 0.5× 51 1.0× 37 418
Philip J. Migliore United States 12 222 2.4× 48 0.5× 70 1.0× 28 0.5× 21 0.4× 17 556
G Mathé France 9 69 0.7× 33 0.4× 37 0.5× 37 0.7× 24 0.5× 48 386
Fumiaki Urase Japan 9 153 1.6× 62 0.7× 66 0.9× 70 1.3× 53 1.1× 22 439
ML Rand Canada 13 314 3.3× 87 1.0× 79 1.1× 30 0.5× 12 0.2× 20 615
James R. Smith United Kingdom 13 41 0.4× 92 1.0× 123 1.7× 27 0.5× 16 0.3× 19 454

Countries citing papers authored by Beaumont Jl

Since Specialization
Citations

This map shows the geographic impact of Beaumont Jl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beaumont Jl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beaumont Jl more than expected).

Fields of papers citing papers by Beaumont Jl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beaumont Jl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beaumont Jl. The network helps show where Beaumont Jl may publish in the future.

Co-authorship network of co-authors of Beaumont Jl

This figure shows the co-authorship network connecting the top 25 collaborators of Beaumont Jl. A scholar is included among the top collaborators of Beaumont Jl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beaumont Jl. Beaumont Jl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cordonnier, C, Sébastien Maury, Hélène Espérou, et al.. (2005). Do minitransplants have minicosts? A cost comparison between myeloablative and nonmyeloablative allogeneic stem cell transplant in patients with acute myeloid leukemia. Bone Marrow Transplantation. 36(7). 649–654. 30 indexed citations
2.
Jl, Beaumont, J Caen, & Jamie J. Bernard. (2003). [Hemorrhagic action of acetylsalicylic acid during blood diseases].. PubMed. 71(27-28). 1087–92.
3.
Jl, Beaumont, et al.. (1985). [Immunogenicity of synthetic sex hormones and thrombogenesis].. PubMed. 33(4). 245–9. 2 indexed citations
4.
Lemort, N, et al.. (1980). Ethinylestradiol and diethylstilbestrol induced antibodies and vascular thrombosis.. PubMed. 32(1). 26–31. 5 indexed citations
5.
Jl, Beaumont, et al.. (1978). [Spontaneous unilateral hematose of the left adrenal gland. Anatomo-clinical study of a case with subacute and favorable course and review of the literature].. PubMed. 129(1). 49–56. 3 indexed citations
6.
Jl, Beaumont & B Jacotot. (1977). [Dietary lipids and atherosclerosis].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 43–52. 1 indexed citations
7.
Jacotot, B & Beaumont Jl. (1977). [Dietary fats, lipidemia and blood coagulation].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 108–11. 1 indexed citations
8.
Girardet, M, et al.. (1977). [Cutaneous cholesterol in coronary disease in man. Comparison of 2 technics of extraction].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 4(1). 59–63. 1 indexed citations
9.
Zittoun, R, et al.. (1975). Macroglobulinémie de Waldenstrôm a activités anticorps anti-hématies conservées et anti-lipoprotéines. 51(48). 1 indexed citations
10.
Jacotot, B, et al.. (1972). [Treatment of hypercholesteremia with cholestyramine].. PubMed. 48(3). 225–30. 1 indexed citations
11.
Jl, Beaumont, et al.. (1970). [Myeloma anti-lipoprotein autoantibodies. Comparative study of 2 types anti-Lp P.G. IgA and anti-Lp A.S. IgG].. PubMed. 28(5). 387–99. 5 indexed citations
12.
Jl, Beaumont. (1969). [A second type of myeloma antilipoprotein autoantibody: IgG anti-Lp A1].. PubMed. 269(1). 107–10. 2 indexed citations
13.
Jl, Beaumont, et al.. (1969). [Passive hemagglutination with chromium chloride. Its use without macromolecular dilution].. PubMed. 17(7). 429–34. 10 indexed citations
14.
Jl, Beaumont. (1967). [The specific activity of the M proteins. "Towards a new criterion for the classification of the myelomas and macroglobulinemias"].. PubMed. 12(4). 319–21. 1 indexed citations
15.
Jl, Beaumont, et al.. (1965). [CHEMICAL COMPOSITION OF SF O-12 LIPOPROTEINS IN FAMILIAL XANTHOMATOUS HYPERCHOLESTEREMIA].. PubMed. 10. 221–4. 1 indexed citations
16.
Jl, Beaumont. (1965). [Hyperlipidemia caused by anti-beta-lipoprotein autoantibodies. A new pathological entity].. PubMed. 261(21). 4563–6. 7 indexed citations
17.
Jl, Beaumont & Daniel R. Schwartz. (1964). [BLOOD CHOLESTEROL AND TRIGLYCERIDES IN 2 OCCUPATIONAL GROUPS. FIRST RESULTS OF AN EPIDEMIOLOGIC INVESTIGATION ON THE FACTORS OF ATHEROSCLEROSIS].. PubMed. 6. 37–50. 1 indexed citations
18.
Jl, Beaumont, Raymond Ardaillou, & J Lenègre. (1958). Recherches sur le métabolisme des lipides dans l'athérosclérose humaine. III. L'épreuve d'hypervitaminémie A provoquée.. 3(10). 3 indexed citations
19.
Caen, J, Beaumont Jl, & J Bernard. (1958). [Deficit of Stuart factor; biological study].. PubMed. 3(2). 161–3. 1 indexed citations
20.
Lenègre, J & Beaumont Jl. (1952). [Anticoagulant therapy of myocardial infarct and intractable angina pectoris].. PubMed. 60(66). 1395–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026